On the next episode of Redefining Medicine, we are excited to feature Dr. Diane Ginsberg, a leading voice in pre- and perimenopause care and a strong advocate for rethinking how we approach women's hormonal health.

IIn this episode, Dr. Ginsberg challenges the traditional reliance on standard blood testing, explaining how hormone levels - particularly estrogen - can fluctuate significantly and still appear "normal" on conventional lab results. She highlights how these fluctuations can profoundly impact the brain and overall well-being, often leaving women misdiagnosed or overlooked within rigid clinical labels.

Looking ahead, Dr. Ginsberg shares her work in developing innovative, AI-driven solutions that integrate genetics and symptom tracking to better assess individual estrogen sensitivity. This forward-thinking approach aims to move beyond outdated frameworks and provide a more personalized, accurate understanding of where a woman falls within the pre-, peri-, or postmenopausal spectrum.

Don't miss this compelling conversation where innovation meets advocacy, and the future of women's health is reimagined through precision, personalization, and a deeper understanding of hormonal complexity.